Verve Therapeutics’ $225 Million Shares Public Offering

Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal.Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease with…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Arthur J. Gallagher & Co.’s Acquisition of Risk International

Stone Point Capital’s Acquisition of a Majority Interest in Kestra Holdings

Graham Partners’ Acquisition of Tulkoff Food Products

Eletromidia’s Public Bidding in the Municipality of Rio de Janeiro

It’sSeg Corretora de Seguros’ Acquisition of Montpelier

Inversiones Wivet’s US$5 Million Investment in Movet

Polenergia S.A.’s PLN750 Million Green Bonds Issuance

Santis Pharma’s Investment Round From Abenex

McMakler’s $21.7 Million Financing Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Bedaya Mortgage Finance’s EGP1.4 Billion Securitized Bond Issuance

Fimi Opportunity Fund’s Acquisition of Maroom Dolphin

Oman Arab Bank S.A.O.G. (OAB)’s OMR10 Million Convertible Bond Issuance

Lesha Bank’s Acquisition of Bereke Bank

Eureka Forbes Limited’s Listing on National Stock Exchange

TasRecycle’s Appointment as Scheme Coordinator for the Tasmanian Government’s Container Refund Scheme

BCI Minerals’ $981 Million Financing for Mardie Salt Project

Paul Hastings Deepens Premier Litigation Team with Complex Commercial Litigator in Washington, D.C.

Curtis Boosts London Finance and Corporate Capability with Appointment of Partner Christopher Harrison

Polsinelli Further Expands Real Estate and Capital Markets Capabilities with New Shareholder in New York and Miami

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Paul Hastings Deepens Premier Litigation Team with Complex Commercial Litigator in Washington, D.C.

Curtis Boosts London Finance and Corporate Capability with Appointment of Partner Christopher Harrison

Polsinelli Further Expands Real Estate and Capital Markets Capabilities with New Shareholder in New York and Miami

Verve Therapeutics’ $225 Million Shares Public Offering

Standard 1 Year Membership Required

Author: Martina Bellini

Standard 1 Year Membership Required